pills-384846_960_720-150x150-5307011Governor Cuomo says that controlling the cost of prescription drugs will be part of his agenda in 2020. Four bills currently awaiting his signature or veto give him a chance to get started in 2019.

The medication-related bills were passed by the Legislature earlier this year and recently delivered to his office for final action. Each would intervene in the complex drug market in a different way, but all, if signed, are likely to result in higher overall costs for consumers, employers and taxpayers – adding to what are already the highest premiums in the lower 48 states.

The most sweeping of the three measures, A. 2836/S. 6531, seeks to regulate pharmacy benefit managers (PBMs), the companies that negotiate prices with drug manufacturers on behalf of health plans and employers.

Because the price-setting process is so murky, and because PBMs generate substantial revenues without ever physically handling a product, they are widely distrusted by other players in the health-care system and state lawmakers of both parties.

The regulation bill, cosponsored by Assembly Health Chairman Richard Gottfried and Senate Insurance Chairman Neil Breslin, easily passed in both chambers with bipartisan support – 147-0 in the Assembly and 49-13 in the Senate.

However, the final language came together quickly in the final days of the legislative session, and includes several problematic provisions.

One requires PBMs to act “for the best interests primarily of the covered individual, and the health plan and the provider” – which would be difficult, since the interests of those three groups often conflict. Another clause creates the right to sue PBMs “for any injury or loss … caused by any violation of such duties, obligations or requirements,” which is bound to unleash a lot of costly litigation.

As written, the bill would also subject the companies to overlapping regulation by two state agencies, the departments of Health and Financial Services, which is likely to create redundancy and conflict.

For these and other reasons, the legislation would impede PBMs from fulfilling their core function of negotiating price discounts, which could leave consumers worse off in the end.

A second bill awaiting Cuomo’s final action, A. 2969/S. 2849, would bar insurers from changing their drug formularies (which are often managed by PBMs) in the middle of a plan year. This is meant to protect patients from unexpected coverage changes that could force them to switch medications or pay higher out-of-pocket charges. 

Health plans and employers have objected that this rule would hamstring their ability to manage drug costs – since manufacturers could hike prices early in the year but not lose their formulary slots until months later.

Tellingly, labor unions raised this same objection – and the legislation was promptly amended to exempt collectively bargained plans from its requirements.

The two final bills, A. 2785/S. 3118 and A. 3009/S. 4078, would mandate coverage of drug “synchronization,” in which pharmacies provide partial refills for some medications so that a patient can refill all of his or her prescriptions at once. One bill imposes this requirement on Medicaid, and the other governs private insurance.

The New York Health Plan Association opposes these bills on grounds that they require insurers to pay pharmacists the same fee for partial refills as they do for 30-day refills, which would be likely to increase costs for plans and premium payers.

Earlier this week, Cuomo said his 2020 agenda would include a three-point plan for lowering drug costs: imposing a $100 monthly cap on out-of-pocket insulin costs for insured patients, empowering the Department of Financial Services to investigate price spikes by drug manufacturers, and creating a commission to explore the importation of lower-cost pharmaceuticals from Canada.

The details of those proposals remain to be seen.

Meanwhile, the governor faces a deadline to sign or veto the two drug synchronization bills by Saturday, and the PBM regulation and formulary bills by Dec. 28. Those decisions will be an early signal of how serious he is about truly controlling drug costs.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

New York’s Hospital Industry Ranks Near the Bottom of Two Quality Report Cards

New York's hospitals remain near the bottom of two quality report cards. The state's hospitals received the lowest rate of any state except Nevada and DC. Read More

New York’s ‘Bluest’ Counties Have the Lowest COVID Vaccination Rates for Older Residents

New York's bluest counties are posting the lowest coronavirus vaccination rates for older residents, a striking contrast with the pattern in the U.S. as a whole. The disparity appea Read More

New York’s ‘Single Payer’ Health Plan Would Disrupt Coverage for Out-of-State Commuters, Too

Under the latest version of the single-payer bill – which has broad support on Democrats in the Legislature – hundreds of thousands of commuters from other states would face the replacement of their current health insurance with a Medicaid-like plan funded with tax dollars and managed by Albany. Read More

The Public Can Now See the Vaccine Task Force Recommendations that the Cuomo Administration Held Back

Even as Governor Cuomo touted vaccine approvals by a state-appointed panel of experts, his office was withholding the group's detailed findings from public view. The governor's six- Read More

New York’s Medicaid and Public Health Crises Get Short Shrift in the New State Budget

In spite of an ongoing pandemic and spiraling Medicaid costs, New York's health-care system received surprisingly little attention in the new state budget. On issue after issue, law Read More

Empire State’s new budget is a bridge to nowhere

Looking ahead to an uncertain post-pandemic recovery, New York’s newly enacted state budget for fiscal year 2022 raises spending by staggering amounts that—barring an unlikely rapid return to peak 2019 economic activity in New York City—can't possibly be sustained for more than a few years. The budget is a mid-2020s fiscal disaster in the making: an incomplete bridge over a deepening river of red ink. Read More

New York Lags in COVID-19 Vaccinations for Older Residents

In the race to vaccinate its oldest and most vulnerable residents, New York has fallen behind. Although the state's overall COVID-19 vaccination rate is somewhat higher than the nat Read More

Lawmakers Mull Medicaid Proposals That Would Speed New York Toward a Fiscal Cliff

As a budget deal nears in Albany, reining in spiraling Medicaid costs seems to be the last thing on anyone's mind. Governor Cuomo is advancing only Read More

Subscribe

Sign up to receive updates about Empire Center research, news and events in your email.

CONTACT INFORMATION

Empire Center for Public Policy
30 South Pearl St.
Suite 1210
Albany, NY 12207

Phone: 518-434-3100
Fax: 518-434-3130
E-Mail: info@empirecenter.org

About

The Empire Center is an independent, non-partisan, non-profit think tank located in Albany, New York. Our mission is to make New York a better place to live and work by promoting public policy reforms grounded in free-market principles, personal responsibility, and the ideals of effective and accountable government.

Empire Center Logo "...the Empire Center is the think tank that spent months trying to pry Covid data out of Mr. Cuomo's government, which offered a series of unbelievable excuses for its refusal to disclose...five months after it (the Empire Center) sued, Team Cuomo finally started coughing up some of the records." -Wall Street Journal, February 19, 2021

SIGN UP TO READ ABOUT THE ISSUES IMPACTING NEW YORKERS.

Empire Center Logo Enjoying our work? Sign up for email alerts on our latest news and research. Together, we can make New York a better place to live and work!

  • For targeting local content